Delivery Order 47QSWA20D007S-75H71026F80038
- The Indian Health Service awarded a delivery order valued at $26,419.76 to Medtox Laboratories Inc. for drug screening supplies supporting the Laboratory Department at a facility in Burlington, North Carolina. This award, finalized on December 31, 2024, represents modifications (MOD 2 and MOD 3) that extend the contract end date through March 31, 2026, each extending the period by one month. The contract employs firm fixed pricing and was awarded without set-aside designation, indicating open...
- The Indian Health Service awarded a $125,168.30 firm fixed-price purchase order to Medtox Diagnostics, Inc. for urine drug screening and confirmatory testing services, with performance completion targeted for September 30, 2025. The contract, awarded December 10, 2021, involves de-obligating excess funds totaling $23,760.43 from two line items. Medtox Diagnostics, a subsidiary of Laboratory Corporation of America Holdings (Labcorp) based in Burlington, North Carolina, will perform the work in...
- The Indian Health Service awarded a firm fixed-price purchase order to Medtox Diagnostics, Inc. valued at $46.5K for urine drug testing kits. The contract, which carries no set-aside designation, was awarded on November 7, 2025, with performance scheduled through September 30, 2026, and will be executed in Albuquerque, New Mexico. Medtox Diagnostics, a subsidiary of Laboratory Corporation of America Holdings (LabCorp) based in Burlington, North Carolina, specializes in laboratory testing...
- This federal contract award, valued at $19,779.60, was issued by the Indian Health Service (IHS), a civilian agency within the U.S. Department of Health and Human Services, to Medtox Laboratories Inc., a division of Laboratory Corporation of America Holdings. The contract is for the purchase of 12 drug screening panels and does not have a set-aside designation, indicating open competition. Medtox Laboratories holds a Multiple Award Schedule (MAS) contract with the General Services...
- This federal contract award was issued by the Indian Health Service (IHS), a civilian agency within the U.S. Department of Health and Human Services, to Medtox Laboratories Inc., a division of Laboratory Corporation of America Holdings. The $23,490.34 firm-fixed-price delivery order was placed against Medtox's General Services Administration (GSA) Multiple Award Schedule (MAS) contract. The contract provides laboratory supplies, including drug screening test kits, analyzer test cartridges, and...
- This federal contract award is for a one-year supply of drugs of abuse reagents for the Indian Health Service (IHS) Pine Ridge Service Unit. The $58,719.94 firm fixed-price delivery order was issued to Medtox Laboratories Inc., a division of Laboratory Corporation of America Holdings, under the company's Multiple Award Schedule (MAS) contract with the General Services Administration. The supplies, which include drug screening test kits and analyzer test cartridges, will be delivered between...
- The Indian Health Service awarded a $26,344.36 firm fixed-price purchase order to Medtox Diagnostics, Inc. for drugs of abuse testing supplies on December 28, 2020, with an ultimate completion date of September 16, 2024. The contract, which has been closed out, was performed in Crownpoint, New Mexico and was awarded without a set-aside designation. Medtox Diagnostics, a subsidiary of Laboratory Corporation of America Holdings (LabCorp), is a manufacturer of laboratory testing products and...
- The Department of Health and Human Services Indian Health Service awarded a $20,078.10 firm fixed price delivery order contract to Medtox Laboratories, Inc. for drug test profiles and supplies. Medtox Laboratories, Inc. will deliver the requested products and services under the Multiple Award Schedule contract vehicle. Performance will take place in Burlington, North Carolina through October 31, 2021. Medtox Laboratories is a division of Laboratory Corporation of America Holdings. This...
- The Department of Health and Human Services Indian Health Service awarded a $10,182.21 delivery order contract to Medtox Laboratories, Inc. for drug profile and supplies. Medtox Laboratories, Inc. will deliver the requested products and services under the Multiple Award Schedule contract vehicle. The contract has no set-aside designation and requires completion by December 5, 2022. Performance will take place in Burlington, North Carolina. Medtox Laboratories, Inc. is a division of Laboratory...
- Medtox Laboratories Inc., a division of Laboratory Corporation of America Holdings, has received a $46,457.76 delivery order from the Department of Health and Human Services Indian Health Service (IHS) for laboratory equipment and supplies. The firm fixed price order was issued against Medtox's Law Enforcement & Security Services (FSS-84) Multiple Award Schedule contract with the General Services Administration, with no set-aside designation. The products will be delivered to the IHS...
- Multiple Award Schedule (MAS)Master GSA Schedule
- 47QSWA20D007SFederal Supply Schedule
- 47QSWA20D007S-75H71026F80038Delivery Order
The Indian Health Service (IHS) awarded a delivery order valued at $41,246.60 to Medtox Laboratories Inc. for the procurement of urine drug screening and testing supplies for the Laboratory Department at Keystone Health Center (KHC) in Burlington, North Carolina. This contract was issued on April 1, 2026, with an ultimate completion date of March 31, 2027, and operates under a firm fixed-price arrangement. The award was made through Medtox's General Services Administration Multiple Award Schedule (MAS) contract, which serves as the primary contracting vehicle for the company's federal work. No set-aside designation was utilized, indicating the award resulted from open competition. Medtox Laboratories Inc., a division of Laboratory Corporation of America Holdings and based in St. Paul, Minnesota, specializes in drug screening, clinical testing, and laboratory supply solutions for federal agencies. The company has established a substantial track record with the IHS, consistently providing drug screening panels, testing kits, and laboratory resources to IHS facilities across multiple states. This delivery order aligns with Medtox's core business focus on supporting healthcare and substance abuse screening programs within the federal government, leveraging the company's expertise in laboratory diagnostics and testing supplies to support IHS operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $41.2k | 3/25/26 |